Cutaneous metastatic carcinoma, also known as carcinoma erysipeloides, is an unusual clinical finding. In women, it is most frequently found in association with breast cancer rather than other visceral malignancies. Breast cancer patients can present with cutaneous manifestations of breast disease at the time of their initial diagnosis; however, cutaneous metastases more often present well after the initial diagnosis and treatment of the breast disease. Prompt recognition of skin metastases by the plastic surgeon, especially during the delayed setting of reconstructive surgery following mastectomy, allows for earlier intervention in treating the systemic spread of the disease. A clinical case of carcinoma erysipeloides presenting in this delayed setting is outlined in the present report, along with a review of the literature.
Key Words: Breast cancer; Carcinoma erysipeloides; Cutaneous metastasesUn carcinome cutané métastatique du sein : Un rapport de cas et une analyse bibliographiqueLe carcinome cutané métastatique, ou carcinome érysipéloïde, est une observation clinique inhabituelle. Chez les femmes, il s'associe plutôt au cancer du sein qu'aux autres tumeurs malignes viscérales. Les patientes atteintes du cancer du sein peuvent présenter des manifestations cutanées de ce cancer au moment du diagnostic. Cependant, les métastases cutanées font beaucoup plus souvent leur apparition bien après le diagnostic initial et le traitement de la maladie cancéreuse. Un dépistage rapide des métastases cutanées par le chirurgien plastique, notamment dans le cadre reporté de la chirurgie reconstructive après une mastectomie, permet une intervention plus rapide pour éviter la propagation systémique de la maladie. Le présent rapport expose un cas clinique de carcinome érysi-péloïde, de même qu'une analyse bibliographique dans un tel contexte. C utaneous metastatic carcinoma is an unusual clinical finding. Review of the literature indicates that the incidence of cutaneous metastases for all types of carcinomas ranges from 0.7% to 10.0% (1-3). Similarly, a more recent meta-analysis (4) demonstrated the overall incidence to be closer to 5.3%. Metastatic cutaneous lesions are more often found in women with breast cancer, than in those with other visceral malignancies, with an incidence exceeding 20% (3-6). Often, the cutaneous lesions do not become apparent until quite some time has passed from the initial treatment of the original carcinoma.